Philanthropic capital has played and will continue to play a critical role as we rebuild after the pandemic. According to the Center for Disaster Philanthropy, more than $20 billion in global philanthropic funding was invested in response to the COVID-19 crisis.
At the Milken Institute's Center for Strategic Philanthropy (CSP), we are heartened by this influx of capital. CSP has consistently advocated for getting philanthropic dollars off the sidelines with real urgency by spending down donor-advised funds (DAFs) and increasing foundation payouts. However, without vigilance, philanthropy can become (and in some cases, already is) plutocratic, nontransparent, wasteful, and rife with unintended consequences—harmful and otherwise.
One of the most worrisome of these unintended consequences is the very real possibility that well-meant donations may perpetuate the very problem they are intended to eradicate. Some prime examples of this reality—CSP calls it "the philanthropist’s dilemma"—are the following: Support to homeless shelters can exacerbate homelessness, giving to higher education in the US may further entrench inequalities instead of redressing them, and donations to hunger relief organizations in the US can actually reinforce income inequality and food insecurity.
This report offers tangible solutions to solve the philanthropist’s dilemma and advocates for the urgent investments required to dismantle the inequitable, racist, and draining systems structures entrenched in this country and throughout the globe.
Fear, anxiety and social isolation brought on by the pandemic has exacerbated existing mental health challenges for people on college campuses, and created new ones as online learning expands, key rites of passage are cancelled, and social...
Corporate philanthropy is in transition. External trends and heightened stakeholder expectations have placed new pressures on the corporate sector. This report, based on extensive interviews with corporate philanthropy executives, explores...
SINGAPORE — The Milken Institute will bring together regional and global leaders representing more than 20 countries for its fifth annual Asia Summit in Singapore. The program, which will be held 13-14 September 2018, will address the...
More than 500,000 people in the US suffer from bladder cancer. At the time of this report, it was the fifth most common cancer in the US. It is also the most expensive cancer to treat and frequently reoccurs. Despite the fact that the...
Leber Hereditary Optic Neuropathy (LHON) is a rare disease that causes sudden, irreversible loss of vision, often striking during adolescence or early adulthood. Patients with LHON quickly lose their ability to recognize faces, drive, and...
The four-day, in-person event features nearly 600 speakers whose expertise and creativity are reinventing health, finance, technology, philanthropy, industry, and media. Los Angeles – October 16, 2021 – The 24th annual Milken Institute...
Chad Clinton is the director of media relations for the Milken Institute. Hired to this role in August 2021, Clinton develops and executes strategies to amplify the Institute’s core messages by generating coverage of its pillar workstreams, experts, and events.
Throughout the COVID-19 crisis, scientists, policymakers, health-care workers, and average citizens worldwide mobilized in ways never seen before to mitigate the challenge at hand. From rapid vaccine development to securing PPE and...
Corporate philanthropy—the efforts companies make to give back to their communities and the world—plays a unique and vital role within the philanthropic sector.
History has shown that governments tend to deprioritize environmental commitments during times of financial and public crises as they work to mitigate immediate needs—and the age of COVID-19 has been no different. Even though human...
How individuals choose to organize and deploy their philanthropic capital can be a daunting decision. Philanthropic giving has no one-size-fits-all equation due to the various vehicles and mechanisms available for philanthropists. Every...
Opening September 19 in Singapore, global and regional leaders will address trends, innovations, and disruptions at the forefront of the regional agenda SINGAPORE, September 18, 2019 – More than 1,500 international leaders in finance...
With no effective therapies and no cure, Neurofibromatosis Type 1 (NF1) is a genetic disease that can cause a broad range of abnormalities all throughout the body. A hallmark feature of the disease is the growth of tumors on nerves...